The Centre Saint-Jean

What The Centre Saint-Jean does

The Centre Saint-Jean, operating as the Institut de Cancérologie du Centre (ICC), is a private French oncology and radiotherapy facility headquartered in Saint-Doulchard, near Bourges, and founded in 1967. ICC delivers integrated cancer treatment to patients across the Centre-Val de Loire and Auvergne-Rhône-Alpes regions, operating three physical treatment centers in Saint-Doulchard, Châteauroux, and Moulins, with advanced consultations offered at three additional locations in Saint-Montrond-Montrond, Vierzon, and Issoudun. The institute's service portfolio is structured around three integrated care lines: radiotherapy delivered via two particle accelerators using ionizing rays to target tumor cells while preserving surrounding healthy tissue; chemotherapy involving cytotoxic drug administration, used alone or in combination with other modalities to reduce tumor size, limit spread, or eliminate residual cancer cells; and supportive care covering pain management, nutritional follow-up, psychological support, and adapted physical activity to improve patient quality of life during treatment. ICC operates a fee-for-service professional services model reimbursed primarily through the French public healthcare system (Sécurité Sociale) and complementary mutuelles, with patient acquisition conducted via established medical referral pathways rather than direct-to-consumer marketing. The institute employs 75 staff across the network, including 13 radiotherapists and oncologists and 10 medical physicists organized as a multi-disciplinary clinical team. No public revenue figures, ownership structure, or investor relationships are disclosed in the available source data.

Name

The Centre Saint-Jean

Legal name

Institut de Cancérologie du Centre

Website

https://centre-saint-jean.fr

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

51–100 employees

Short description

The Centre Saint-Jean (Institut de Cancérologie du Centre) is a private French oncology center operating three treatment centers across Centre-Val de Loire and Auvergne-Rhône-Alpes, delivering radiotherapy, chemotherapy, and supportive care to cancer patients via a 75-person multi-disciplinary team.

Ownership category

akta.pro rank

Product category

Oncology Treatment Services

NAICS

Outpatient Care Centers (6214)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Oncology treatment services
• Radiotherapy treatments
• Chemotherapy services
• Supportive cancer care
• Radiation oncology

Headquarters

HQ city

Saint-doulchard

HQ country

France

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Radiotherapy Treatments: Radiotherapy services using advanced particle accelerator technology to treat cancer patients. Revenue generated through medical treatment billing, typically reimbursed through the French public healthcare system.
2. Chemotherapy Treatments: Administration of cytotoxic medications for cancer treatment. Services billed through the French healthcare system as part of oncology treatment protocols.
3. Supportive Care Services: Parallel supportive care services including pain management, nutritional support, psychological support, and adapted physical activity programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

The Centre Saint-Jean (Institut de Cancérologie du Centre) is a private oncology facility delivering radiotherapy using 2 particle accelerators, chemotherapy through cytotoxic drug protocols, and comprehensive supportive care services including pain management, nutritional support, psychological counseling, and adapted physical activity. Services are delivered across three treatment centers in Saint-Doulchard (Bourges), Châteauroux, and Moulins, plus advanced consultations at Saint-Montrond-Montrond, Vierzon, and Issoudun.

Product overview

The Institut de Cancérologie du Centre (ICC) is a private oncology center composed of three treatment sites in Centre-Val de Loire and Auvergne-Rhône-Alpes regions. The center offers three core integrated services: Radiotherapy (using ionizing radiation for targeted tumor treatment), Chemotherapy (cytotoxic drug administration), and Supportive Care (pain management, nutrition, psychological support, and adapted physical activity). These three service lines work together as a comprehensive cancer care offering across sites in Saint-Doulchard (Bourges), Châteauroux, and Moulins.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy (Radiothérapie) Radiotherapy uses ionizing radiation to target and destroy tumor cells while preserving surrounding healthy tissues. Delivered to cancer patients through 2 particle accelerators across the institute's treatment centers, with treatments increasingly precise to reduce side effects and improve quality of life.
• Chemotherapy (Chimiothérapie) Chemotherapy involves administration of cytotoxic drugs that act on cancer cells by preventing them from multiplying. Often used in combination with other therapies to reduce tumor size, limit spread, or destroy residual cancer cells after intervention. Delivered to cancer patients across the institute's treatment centers.
• Supportive Care (Soins de support) Supportive care encompasses all care provisions aimed at improving comfort and quality of life of cancer patients, including pain management, nutritional follow-up, psychological support, and complementary approaches such as adapted physical activity. Delivered in parallel with radiotherapy and chemotherapy across the institute's centers.

Quantifiable outcome

• Treatments are increasingly precise, reducing side effects and improving patient quality of life

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Institut Curie: Leading French cancer center combining hospital, research, and teaching across oncology. Provides the same core radiotherapy/chemotherapy modalities as ICC and serves as a benchmark for French private/non-profit oncology, though at much greater scale and complexity.
• Unicancer: Federation of French CLCC cancer centers that sets shared standards, contracting, and strategic direction for member centers. Relevant to ICC as the principal organized competitor/coordinating body in French oncology and as a potential partnership or affiliation counterparty.

Broad incumbents

• GenesisCare: International private oncology network operating radiotherapy and chemotherapy centers across multiple countries including France. Directly comparable to ICC on private-operator, multi-site radiotherapy-center business model, but at vastly greater scale and geographic reach.
• Gustave Roussy: Largest European cancer center (Villejuif), a CLCC delivering radiotherapy, chemotherapy, and supportive oncology services. Competes with ICC for complex referrals in the broader French market and represents the upper bound of scale ICC's regional model is measured against.
• Centre Léon Bérard: CLCC comprehensive cancer center in Lyon offering radiotherapy, chemotherapy, and supportive care with a large multi-specialist team. Comparable to ICC on the integrated oncology service line but operates at substantially larger scale and with research/academic affiliations ICC does not disclose.
• Centre Oscar Lambret: CLCC regional cancer center in Lille offering the same integrated radiotherapy/chemotherapy/supportive care model as ICC. Comparable service lines and French regional positioning, but with larger scale and full CLCC/UNICANCER affiliation.

Regional players

• Institut du Cancer de Montpellier (ICM): CLCC regional cancer center serving the Languedoc-Roussillon area with radiotherapy, chemotherapy, and supportive care. Overlaps with ICC's integrated oncology service mix but operates in a different French region, making it a regional benchmark rather than direct territory competitor.

Direct peers

• Institut de Cancérologie de l'Ouest (ICO): French regional oncology center operating across multiple sites (Angers, Nantes, Saint-Herblain). Most directly comparable to ICC in terms of multi-site private/ESPIC cancer-center model, integrated radiotherapy/chemotherapy/supportive care offering, and regional French footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Centre Saint-Jean